The invention belongs to the technical field of medicines, and particularly relates to application of dihydromyricetin as an active ingredient in sleep disorder. According to the medicine prepared by taking dihydromyricetin as a raw material, the ATP supply of the brain can be increased, the Gephyrin protein level can be increased, and the function of brain inhibitory neurons (GAMA aminobutyric acid) can be improved; the compound can effectively improve the night sleep disorder of a dementia patient, especially the night dysphoria and excitement accompanied by the night sleep disorder, can regulate the function of dopaminergic neurons, plays a role in calming by regulating the function of inhibitory neurons, relieves the phenomena of anxiety, depression and insomnia, and is good in safety and free of dependence, tolerance and other adverse reactions.